×
About 2,043 results

ALLMedicine™ Tooth Extraction Center

Research & Reviews  764 results

Histologic Findings 8 Weeks After Customized Alveolar Ridge-Splitting Technique.
https://doi.org/10.11607/prd.5507
The International Journal of Periodontics & Restorative D... Maketone P, Leung M et. al.

Sep 22nd, 2021 - Different techniques have been introduced when replacement with an implant is planned after tooth extraction. The conventional approach consists of waiting 3 to 4 months before implant placement. However, many other options are available for impla...

Therapeutic effect of fluvastatin on medication-related osteonecrosis of the jaw.
https://doi.org/10.1002/JPER.21-0294
Journal of Periodontology; Sanda K, Ayukawa Y et. al.

Sep 13th, 2021 - Refractory jaw osteonecrosis that occurs in osteoporotic or cancer patients treated with bisphosphonates is called medication-related osteonecrosis of the jaw but its underlying mechanism is unclear. Statins, therapeutic agents for dyslipidemia, l...

Self-Reported Diabetes Mellitus and Tooth Extraction Due to Periodontal Disease and Den...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430558
International Journal of Environmental Research and Publi... Suzuki S, Sugihara N et. al.

Sep 11th, 2021 - Diabetes mellitus is closely related to oral health. We aimed to determine the relationship between diabetes mellitus and tooth extraction due to periodontal disease and dental caries. Japan's second nationwide survey data collected from 4 June to...

Biologic and pathologic aspects of osteocytes in the setting of medication-related oste...
https://doi.org/10.1016/j.bone.2021.116168
Bone Aguirre JI, Castillo EJ et. al.

Sep 7th, 2021 - Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe, debilitating condition affecting patients with cancer and patients with osteoporosis who have been treated with powerful antiresorptives (pARs) or angiogenesis inhibitors...

Effect of alveolar ridge preservation on clinical attachment level at adjacent teeth: A...
https://doi.org/10.1111/cid.13040
Clinical Implant Dentistry and Related Research; Khouly I, Strauss FJ et. al.

Aug 28th, 2021 - To test whether or not alveolar ridge preservation (ARP) changes the clinical attachment level (CAL) at adjacent teeth of extraction sockets after 6 months. Seventeen patients requiring bilateral tooth extractions of the upper molars were recruite...

see more →

Drugs  36 results see all →

News  17 results

Mouth Splints Decrease Risk of Post-Dental Extraction Bleeding in Hemophilia
https://www.medscape.com/viewarticle/940367

Nov 4th, 2020 - Dental extractions can cause significant risk of bleeding in hemophilia patients being treated with factor replacements. However, mouth splints significantly decreased the risk of postextraction bleeding in these patients, according to Takahiro Ya...

Mouth Splints Decrease Risk of Post-Dental Extraction Bleeding in Hemophilia
https://www.staging.medscape.com/viewarticle/940367

Nov 4th, 2020 - Dental extractions can cause significant risk of bleeding in hemophilia patients being treated with factor replacements. However, mouth splints significantly decreased the risk of postextraction bleeding in these patients, according to Takahiro Ya...

Treatment of Melasma Using Tranexamic Acid: What’s Known and What’s Next
https://www.mdedge.com/dermatology/article/159214/pigmentation-disorders/treatment-melasma-using-tranexamic-acid-whats
Sarah L. Sheu, MD

Feb 22nd, 2018 - Tranexamic acid is a synthetic lysine derivative that inhibits plasminogen activation by blocking lysine-binding sites on the plasminogen molecule. Although the US Food and Drug Administration–approved indications for tranexamic acid include treat.

Teach your adolescent patients about normal menses, so they know when it’s abnormal
https://www.mdedge.com/familymedicine/article/151250/adolescent-medicine/teach-your-adolescent-patients-about-normal-menses/page/0/1
Pediatric News;

Nov 6th, 2017 - Von Willebrand syndrome Von Willebrand syndrome is a deficiency or dysfunction of von Willebrand factor (vWF), a protein with binding sites for platelets, collagen, and factor VIII that “serves as a bridge between platelets and injury sites in ves.

FDA approves generic tranexamic acid
https://www.mdedge.com/hematology-oncology/article/185551/thrombosis/fda-approves-generic-tranexamic-acid
HT Staff

Jul 21st, 2017 - Photo by Bill Branson Vials of drug Zydus Cadila has received approval from the US Food and Drug Administration (FDA) to market a tranexamic acid product for use in patients with hemophilia. The company’s product—Tranexamic Acid Injection, 1000 mg.

see more →